Haymarket Launches a New Resource for Clinicians Treating Diabetes and Other Endocrine Disorders

New York, September 9, 2014. Haymarket Media is excited to announce the launch of EndocrinologyAdvisor.com, a new digital resource for healthcare professionals in the field of endocrinology.

EndocrinologyAdvisor.com is designed to provide practical, actionable information and resources to assist clinicians in making the right decisions for their patients affected by diabetes and other endocrine conditions. 

Key features include: daily endocrinology news, drug monographs, full-length clinical features, unique case studies, clinical charts, continuing medical education (CME) courses, and coverage from major endocrinology conferences.

"Our goal is to provide clinicians—endocrinologists, physician assistants, nurse practitioners, and primary care physicians who treat patients affected by endocrine disorders—with the latest relevant clinical information and treatment strategies to ensure exceptional patient care," said Jim Burke, RPh, SVP, Digital Products at Haymarket Media. 

Members of Endocrinology Advisor's editorial board—who provide guidance and will be regular contributors—include:

    • George Grunberger, MD, FACP, FACE, President-Elect of the American Association of Clinical Endocrinologists and founder of the Grunberger Diabetes Institute.

    • Pauline Camacho, MD, FACE, Vice President of the American Association of Clinical Endocrinologists and Professor of Medicine and Director of the Loyola University Osteoporosis and Metabolic Bone Disease Center.

    • Elizabeth N. Pearce, MD, MSc, Associate Professor of Medicine at Boston University School of Medicine and member of the board of directors for the American Thyroid Association.

    • Marc R. Blackman, MD, Associate Chief of Staff for Research & Development at the Washington DC Veterans Affairs Medical Center and Assistant Dean for VA Research and Professor of Medicine & Rehabilitation Medicine at Georgetown University School of Medicine.   

EndocrinologyAdvisor.com is mobile-optimized and will also be released as a native app for Apple iOS (iPhone, iPad, iPod Touch) and Android devices in coming weeks.

The Endocrinology Advisor website and app is the second in a series of new digital resources Haymarket Media will launch as part of its Advisor Network, building on the success of The Clinical Advisor and Cancer Therapy Advisor brands. The first brand in the series Psychiatry Advisor was launched in July 2014 for psychiatric healthcare professionals.

For more information, contact:

Melissa Foster, Digital Content Editor
Email: melissa.foster@haymarketmedia.com
Tel: 646.638.6214

Matt Dechen, Director of Business Development, Cardiometabolics

Email: matthew.dechen@haymarketmedical.com
Tel: 646.954.6113

 

About Haymarket Media, Inc.

Haymarket Media Inc. (HMI), a global publication and communications company founded in 1957 with North American Headquarters in New York City, publishes titles in 23 languages and in more than 100 nations.

The Haymarket Medical Network reaches healthcare practitioners through a multichannel environment that includes more than 11 unique brands offered across multiple formats (web, app, print, live), including: 

MPR—including Physician Assistant, Nurse Practitioner, Pediatrician, and Pharmacist editions—The Clinical Advisor, Cancer Therapy Advisor, The Cardiology Advisor, Endocrinology Advisor, Clinical Pain Advisor, Infectious Disease Advisor, Oncology Nurse Advisor, Neurology Advisor, Psychiatry Advisor, Renal & Urology News, Rheumatology Advisor, Medical Bag, and  the ONA Nurse Navigation Summit.

The network benefits from its inter-connectivity, allowing users to move from brand to brand to discover the relevant content they need to make practice-related decisions.

Since 1985, MPR has been the most used drug reference by healthcare professionals in a wide variety of specialties and practice settings.

RELATED LINKS
http://www.haymarketmedia.com
http://www.haymarketmedicalnetwork.com

http://www.empr.com

 

SOURCE Haymarket Media Inc.